Your Twin learns with you

30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Gaetano Gargiulo

Has grant

Group Leader

Max Delbrück Center for Molecular Medicine in the Helmholtz Association
Country flagGermany

Research Interests

Explore related searches

Recent Grants

Grant: Close

Generation, validation and use of a synthetic reporter of CAR T cell products function and dysfunction

Open Date: 2024-03-01

Close Date: 2025-08-01

Grant: Close

Generation and validation of a panel of EMT reporter cell lines from solid tumors

Open Date: 2022-07-01

Close Date: 2023-12-01

Grant: Close

Glioblastoma Subtype Avatar models for Target Discovery and Biology

Open Date: 2017-07-01

Close Date: 2023-06-01

Grant: Close

Testing therapeutic response to Polycomb inhibition in preclinical mouse models of Kras mutant lung cancer

Open Date: 2015-10-01

Close Date: 2018-10-01

Grant: Close

Functional identification of novel genes implicated in Glioblastoma Multiforme

Open Date: 2013-01-01

Close Date: 2016-01-01

Articles (8)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Tumors represent ecosystems where subclones compete during tumor growth. While extensively investigated, a comprehensive picture of the interplay of clonal lineages during dissemination is still lacking. Using patient-derived pancreatic cancer cells, we created orthotopically implanted clonal replica tumors to trace clonal dynamics of unperturbed tumor expansion and dissemination. This model revealed the multifaceted nature of tumor growth, with rapid changes in clonal fitness leading to continuous reshuffling of tumor architecture and alternating clonal dominance as a distinct feature of cancer growth. Regarding dissemination, a large fraction of tumor lineages could be found at secondary sites each having distinctive organ growth patterns as well as numerous undescribed behaviors such as abortive colonization. Paired analysis of primary and secondary sites revealed fitness as major contributor to dissemination. From the analysis of pro- and nonmetastatic isogenic subclones, we identified a transcriptomic signature able to identify metastatic cells in human tumors and predict patients’ survival.

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (15)

Deniz Demircioglu

Assistant Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Andrea Viale

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Davide Cora'

Associate Professor

Università degli Studi del Piemonte Orientale

ITALY
View details

Daniel Lozano-Ojalvo

Consejo Superior de Investigaciones Cientificas

SPAIN
View details

Viktoria Haug

University Hospital Frankfurt

GERMANY
View details

Sara Sigismund

Principal Investigator

European Institute of Oncology

ITALY
View details

Rutvi Shah

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details

Alberto Ballestín

Beatriz Galindo Professor (Research Talent Attraction, Ministry of Science-MICIU, Spain)

Universidad de Extremadura

SPAIN
View details

Sara Gandini

Group Leader T, PhD

European Institute of Oncology

ITALY
View details

Dario Polli

Associate Professor

Politecnico di Milano

ITALY
View details

Tiziana Bonaldi

Contract Professor

Università degli Studi di Torino

ITALY
View details

Jérémy Raymond

University of Oxford

UNITED KINGDOM
View details

Lukas Chavez

Associate Professor

University of California, San Diego

UNITED STATES
View details

Owen J. Sansom

Director

Cancer Research UK Beatson Institute

UNITED KINGDOM
View details

Linghua Wang

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.